ASH 2021 – Hematological Adverse Event Management

Dr. Jerome Goldschmidt, MD, ​an oncologist at Blue Ridge Cancer Care ​discusses his poster presentation from the American Society of Hematology (ASH) 2021 Annual Meeting titled “Understanding Hematological Adverse Event Management through Health Care Resource Utilization, Costs, and Treatment Patterns of Patients with Extensive-Stage Small Cell Lung Cancer Treated in the Community Oncology Setting” 

Dr. Jerome Goldschmidt obtained a bachelor of arts in German and a minor in chemistry from the University of North Carolina and is a graduate of the University of North Carolina School of Medicine. He completed his fellowship in medical oncology at the University of Rochester/Strong Memorial Hospital, Rochester, New York. Dr. Goldschmidt has contributed to multiple publications and is a member of the American Society of Clinical Oncology. He is board certified in medical oncology and internal medicine.

Dr. Goldschmidt’s interests are cancer survivorship, clinical research and cancer prevention. He also serves as adjunct faculty at Virginia College of Osteopathic Medicine.

In his spare time he enjoys spending time with his wife and children, reading and hiking.

Liked it? Take a second to support healthprofessionalradio on Patreon!


Leave a Reply

You must be logged in to post a comment.